Amedisys Has Earned the 2023 SHPBest Patient Satisfaction Awards
Amedisys Sale to UnitedHealth Unlikely to Be Done Until at Least End of November
Amedisys, Inc.: Michael North, Chief Information Officer, Is Leaving the Company Effective August 31 >AMED
Amedisys CIO Michael North Exits With $3M Severance Package
Express News | Contessa Health, A Subsidiary Of Amedisys Announced They Have Been Selected By The Centers For Medicare & Medicaid Services To Participate In A New Medicare Alternative Payment Model Designed To Support People Living With Dementia And Their Caregivers
Amedisys Cut to Hold From Buy by Deutsche Bank
Express News | Deutsche Bank Downgrades Amedisys to Hold, Maintains Price Target to $101
Express News | Amedisys Inc : Deutsche Bank Cuts to Hold From Buy
Deutsche Bank Downgrades Amedisys to Hold From Buy, Price Target Is $101
TD Cowen Initiates Amedisys(AMED.US) With Hold Rating, Announces Target Price $101
Amedisys: Hold Rating Affirmed Amidst Modest EBITDA Adjustments and Acquisition Offer
Amedisys (AMED) Q2 Earnings Top Estimates, Gross Margin Down
Amedisys Price Target Maintained With a $101.00/Share by Cantor Fitzgerald
Amedisys Analyst Ratings
TD Cowen Maintains Amedisys(AMED.US) With Hold Rating, Maintains Target Price $101
Amedisys | 10-Q: Q2 2024 Earnings Report
Amedisys (AMED) Gets a Hold From TD Cowen
Truist Financial Maintains Amedisys(AMED.US) With Hold Rating
Amedisys Non-GAAP EPS of $1.32 Beats by $0.14, Revenue of $591.2M Beats by $9.38M
Amedisys Releases Q2 Supplemental Financial Slides